United States · FDA National Drug Code directory
Ropivacaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9196_c4abd4d6-435c-4d2a-b670-717af36ceada
- Product NDC
- 0143-9196
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Ropivacaine Hydrochloride
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251107
- Source listing expiry
- 20271231
Source-listed ingredients
- ROPIVACAINE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 12 BAG in 1 CASE (0143-9196-12) / 200 mL in 1 BAG (0143-9196-01) · 0143-9196-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →